Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab. A study published in the Proceedings of the National Academy of Sciences is the first to demonstrate hallmarks of macular degeneration in a new human stem cell model developed by researchers at the University of Rochester Medical Center (URMC).
This new model could make whole new avenues of macular degeneration research possible and has helped the team hone in on some possible drug targets for the disease.
Human induced pluripotent stem cell-retinal pigment epithelium in a dish.
Image credit: Sonal Dalvi (Singh lab, University of Rochester)
“So far, there has not been a patient-derived model of macular degeneration,” said RPB Career Development Award recipient Ruchira Singh, PhD, assistant professor of Ophthalmology in the Flaum Eye Institute at URMC and lead author of the study. “It was not known if you can take cells from the human eye and make a cell model that displays the hallmarks of the disease.”
September 26, 2017
RPB launches awards in data science and Diabetic Eye Disease.
Leaders of organizations that fund vision research convene in Washington DC to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
An RPB grantee makes a key discovery involving genes that are essential for eye health.
RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.
We welcome your generosity to help us meet our goal!
Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |